Your browser does not support javascript


Data-Waiver (X-Waiver) Requirement Removed

Published on Feb 6, 2023

As of December 29, 2022, and pursuant to Section 1262 of the Consolidated Appropriations Act of 2023, federal law no longer requires prescribers to obtain a DATA-Waiver or X-Waiver to prescribe medications, like buprenorphine, to treat patients with opioid use disorder. Read joint statement from DBHDS, DMAS and DHP on the removal of DATA Waiver (X-Waiver) requirement.

Back to News Index

Virginia Board of Pharmacy
Caroline D. Juran, Executive Director
Cheryl L Garvin, RPh, Chairman